Home › Calculator › VOR Dividend Calculator 2026
VOR Dividend DRIP Calculator 2026
9.71% YieldHealthcareVor Biopharma Inc. · NASDAQ
Price: $20.59 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When VOR pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your VOR snowball 📈
$10,000 in VOR → $25.3K in 10 years · $186.44/month
About Vor Biopharma Inc. (VOR) — Dividend Analysis 2026
Vor Biopharma, Inc. is a clinical-stage biotechnology firm dedicated to developing innovative engineered hematopoietic stem cell (eHSC) therapies for individuals battling cancer. Its lead product candidate, VOR33, is an eHSC therapy currently undergoing Phase 1/2 clinical trials. VOR33 is designed to target acute myeloid leukemia (AML) and various other hematological malignancies. A key feature of VOR33's eHSCs is their engineered absence of the CD33 protein, which is commonly found on AML blood cancer cells. The company's eHSC platform is intended to enable a range of targeted blood cancer treatments, including CAR-T cell therapies, bispecific antibodies, and antibody-drug conjugates. Vor Biopharma has established a partnership with Akron BioProducts for the development and manufacturing of cGMP nucleases. Established in 2015, the company's headquarters are located in Cambridge, Massachusetts.
Compare VOR with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full VOR DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open VOR position with:
🌍 VOR Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold VOR.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 9.71% | 6.91% | $971 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 8.25% | 5.45% | $825 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 7.77% | 4.97% | $777 / yr |
| 🇬🇧 UK ISA | 0% | 9.71% | 6.91% | $971 / yr |
| 🇬🇧 UK Taxable | 8.75% | 8.86% | 6.06% | $886 / yr |
| 🇨🇦 TFSA | 0% | 9.71% | 6.91% | $971 / yr |
| 🇨🇦 CA Taxable | 25% | 7.28% | 4.48% | $728 / yr |
| 🇦🇺 Super (pension) | 15% | 8.25% | 5.45% | $825 / yr |
| 🇦🇺 AU Taxable | 30% | 6.80% | 4.00% | $680 / yr |
| 🇩🇪 DE Taxable | 26.375% | 7.15% | 4.35% | $715 / yr |
| 🇫🇷 FR Taxable | 30% | 6.80% | 4.00% | $680 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 VOR Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 VOR Dividend Payment Schedule
VOR pays quarterly — 4 times per year. Next ex-div: TBD.
📊 VOR vs Healthcare Benchmarks
How VOR compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for VOR sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ VOR Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| X-InTheMoney | 2026-07-16 | 2,100,000 | $0.00 | $4.2K | ||
| X-InTheMoney | 2026-07-16 | 2,100,000 | $0.00 | $4.2K | ||
| Sale | 2026-07-16 | 213 | $19.75 | $4.2K | ||
| A-Award | 2026-07-07 | 42,658 | $20.10 | $857.4K | ||
| A-Award | 2026-06-11 | 57,162 | $14.09 | $805.4K | ||
| A-Award | 2026-06-11 | 57,162 | $14.09 | $805.4K | ||
| A-Award | 2026-06-11 | 56,549 | $14.09 | $796.8K | ||
| A-Award | 2026-06-11 | 57,162 | $14.09 | $805.4K | ||
| A-Award | 2026-06-11 | 57,162 | $14.09 | $805.4K | ||
| A-Award | 2026-06-11 | 56,345 | $14.09 | $793.9K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the VOR dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Vor Biopharma Inc. (VOR) is currently trading at $20.59, 98% below its 52-week high. The current dividend yield is 9.71% based on an annual payout of $2.00 per share.
VOR (Vor Biopharma Inc.) — 9.71% Dividend Yield Analysis
Vor Biopharma Inc. (VOR) is a healthcare stock currently trading at $20.59 with a dividend yield of 9.71%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (9.71%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.